Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07249216
What this trial is testing

Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting

Who this might be right for
Age Related Macular Degeneration
Singapore National Eye Centre 117
Post-approval studies (Phase 4)Study completedNCT00324116
What this trial is testing

Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions

Who this might be right for
Macular Degeneration
Pfizer 81
Large-scale testing (Phase 3)Study completedNCT00826371
What this trial is testing

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients

Who this might be right for
Age Related Macular Degeneration
Novartis Pharmaceuticals 114
Not applicableStudy completedNCT01348581
What this trial is testing

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

Who this might be right for
Pressure UlcersVenous UlcersDiabetic Ulcers+2 more
Kerecis Ltd. 37
Not applicableWithdrawnNCT00813514
What this trial is testing

Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?

Who this might be right for
Choroidal NeoVascularizationAge-Related Macular Degeneration
Medical University of Vienna
Testing effectiveness (Phase 2)Looking for participantsNCT07637981
What this trial is testing

First Clinical Study to Evaluate Safety, Tolerability & PK of DX243 in Healthy Volunteers and Patients With Hearing Loss

Who this might be right for
Age-related Hearing Loss
Dendrogenix 24
Not applicableStudy completedNCT00578981
What this trial is testing

Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women

Who this might be right for
OsteoporosisBone Loss, Age RelatedPostmenopausal Bone Loss+1 more
Mayo Clinic 100
Early research (Phase 1)Active Not RecruitingNCT05823571
What this trial is testing

Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

Who this might be right for
Leukemia, AcuteMyelodysplastic SyndromesMyelomonocytic Leukemia, Chronic+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Not applicableUnknownNCT03720964
What this trial is testing

Mitochondrial Genetics of Presbycusis

Who this might be right for
PresbycusisAge Related Hearing Loss
University Hospital, Angers 200
Not applicableStudy completedNCT01245387
What this trial is testing

Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related Macular DegenerationNeovascular Macular Degeneration
Pfizer 1,001
Not applicableLooking for participantsNCT06599021
What this trial is testing

Swallowing Difficulties in People Over 60 Years: Prevalence, Degree of Difficulty and Intervention

Who this might be right for
DysphagiaInterventionAgeing
Lisa Tuomi 99
Not applicableStudy completedNCT01334736
What this trial is testing

Novel Smoking Cessation Interventions in Current and Former Injection Drug Users

Who this might be right for
Tobacco Dependence
Johns Hopkins University 100
Not applicableStudy completedNCT01480700
What this trial is testing

Consumption of Eggs Rich in Lutein and Omega-3 Fatty Acids on the Macular Pigment

Who this might be right for
Age-related Macular Degeneration
Institut Pasteur de Lille 99
Large-scale testing (Phase 3)Ended earlyNCT01940887
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 645
Testing effectiveness (Phase 2)Ended earlyNCT00414206
What this trial is testing

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
CoMentis 343
Testing effectiveness (Phase 2)Study completedNCT06164587
What this trial is testing

Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Inflammasome Therapeutics 30
Large-scale testing (Phase 3)Study completedNCT00523406
What this trial is testing

Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)

Who this might be right for
Macular Degeneration
Medical University of Vienna 40
Not applicableNot Yet RecruitingNCT05914233
What this trial is testing

Non-invasive Ultrasound Retinal Stimulation for Vision Restoration

Who this might be right for
Age-Related Macular DegenerationRetinitis PigmentosaUltrasound Therapy; Complications
University of Southern California 5
Testing effectiveness (Phase 2)Study completedNCT00766649
What this trial is testing

Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMD

Who this might be right for
Age-Related Macular Degeneration
National Eye Institute (NEI) 11
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Next Page